Alternative Funding Programs vs. In-Benefit Optimization: Designing a Sustainable Specialty Drug Strategy
Specialty medications are expanding what is clinically possible, but not without a price. The affordability gap on these therapies continues to widen, placing sustained pressure on health plan budgets. U.S.…